| JAK inhibitors for alopecia areata: a systematic review and meta‐analysis K Phan, DF Sebaratnam Journal of the European Academy of Dermatology and Venereology 33 (5), 850-856, 2019 | 146 | 2019 |
| Quality of life in non‐melanoma skin cancer C Gaulin, DF Sebaratnam, P Fernández‐Peñas Australasian Journal of Dermatology 56 (1), 70-76, 2015 | 84 | 2015 |
| Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire DF Sebaratnam, AM Hanna, S Chee, JW Frew, SS Venugopal, BS Daniel, ... JAMA dermatology 149 (10), 1186-1191, 2013 | 82 | 2013 |
| Methotrexate for alopecia areata: a systematic review and meta-analysis K Phan, V Ramachandran, DF Sebaratnam Journal of the American Academy of Dermatology 80 (1), 120-127. e2, 2019 | 77 | 2019 |
| The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in … A Tjokrowidjaja, BS Daniel, JW Frew, DF Sebaratnam, AM Hanna, ... British Journal of Dermatology 169 (5), 1000-1006, 2013 | 76 | 2013 |
| Infantile hemangioma. Part 1: epidemiology, pathogenesis, clinical presentation and assessment AIR Bandera, DF Sebaratnam, O Wargon, LCF Wong Journal of the American Academy of Dermatology 85 (6), 1379-1392, 2021 | 71 | 2021 |
| Evolving role of Instagram in# medicine XL Wong, RC Liu, DF Sebaratnam Internal medicine journal 49 (10), 1329-1332, 2019 | 71 | 2019 |
| Wikipedia use amongst medical students-New insights into the digital revolution. UK Allahwala, A Nadkarni, DF Sebaratnam Medical teacher, 2012 | 62 | 2012 |
| Bullous systemic lupus erythematosus DF Sebaratnam, DF Murrell Dermatologic clinics 29 (4), 649-653, 2011 | 56 | 2011 |
| Comparison of narrowband UV-B with psoralen–UV-A phototherapy for patients with early-stage mycosis fungoides: a systematic review and meta-analysis K Phan, V Ramachandran, H Fassihi, DF Sebaratnam JAMA dermatology 155 (3), 335-341, 2019 | 55 | 2019 |
| Infantile hemangioma. Part 2: management DF Sebaratnam, LCF Wong, O Wargon Journal of the American Academy of Dermatology 85 (6), 1395-1404, 2021 | 53 | 2021 |
| Quality of life in patients with bullous dermatoses DF Sebaratnam, JR McMillan, VP Werth, DF Murrell Clinics in dermatology 30 (1), 103-107, 2012 | 52 | 2012 |
| Diffuse melanosis cutis: a systematic review of the literature DF Sebaratnam, SS Venugopal, JW Frew, JR McMillan, ER Finkelstein, ... Journal of the American Academy of Dermatology 68 (3), 482-488, 2013 | 41 | 2013 |
| Subacute cutaneous lupus erythematosus induced by nivolumab RC Liu, DF Sebaratnam, L Jackett, S Kao, PM Lowe Australasian Journal of Dermatology 59 (2), e152-e154, 2018 | 40 | 2018 |
| Quality-of-life measurement in blistering diseases DF Sebaratnam, JW Frew, F Davatchi, DF Murrell Dermatologic clinics 30 (2), 301-307, 2012 | 40 | 2012 |
| Recommendations on dermatologic surgery during the COVID-19 pandemic SA Der Sarkissian, L Kim, M Veness, E Yiasemides, DF Sebaratnam Journal of the American Academy of Dermatology 83 (1), e29-e30, 2020 | 35 | 2020 |
| Sirolimus in blue rubber bleb naevus syndrome: A systematic review XL Wong, K Phan, AI Rodriguez Bandera, DF Sebaratnam Journal of paediatrics and child health 55 (2), 152-155, 2019 | 34 | 2019 |
| Lasers and laser‐like devices: Part two DF Sebaratnam, AC Lim, PM Lowe, GJ Goodman, P Bekhor, S Richards Australasian Journal of Dermatology 55 (1), 1-14, 2014 | 34 | 2014 |
| Atypical fibroxanthoma management: recurrence, metastasis and disease‐specific death MM Polcz, DF Sebaratnam, P Fernández‐Peñas Australasian Journal of Dermatology 59 (1), 10-25, 2018 | 33 | 2018 |
| Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA DF Sebaratnam, J Okawa, A Payne, DF Murrell, VP Werth Quality of Life Research 24, 2257-2260, 2015 | 31 | 2015 |
John W FrewUniversity of New South WalesVerified email at unsw.edu.au
